Everspan organizes published research for informational purposes only. This is not medical advice. Consult a healthcare provider before starting any intervention.
Trending
Back to Atlas
T2· OptimizationB-· PromisingOtherOther
Gut Health

Gut Microbiome Testing

Direct-to-consumer testing to analyze gut bacterial composition and diversity for personalized health insights.

Human Trials

45

12,800 participants

Risk Level

Low Risk

Monthly Cost

$100$400 /month

One-time testing typically $100-400, some companies offer subscription models

Quick Facts

Category
Other
Research Field
Other
Evidence Grade
B- – Promising
Risk Level
Low
Monthly Cost
$100 – $400
Human Trials
45

Research Velocity

+9%
180 publications in the last 12 months · steady increase in publications

Mechanism of Action

Gut microbiome testing analyzes bacterial DNA from stool samples using 16S rRNA gene sequencing or shotgun metagenomics to identify and quantify microbial species. Research indicates that microbiome composition correlates with various health outcomes including immune function, metabolic health, and inflammation markers. Studies suggest that microbiome diversity and specific bacterial ratios may serve as biomarkers for disease risk and treatment response.

Overview

Gut microbiome testing has emerged as a popular direct-to-consumer health assessment tool that analyzes the bacterial composition of stool samples. Research indicates that the gut microbiome plays crucial roles in immune function, metabolism, and overall health, with studies suggesting that specific bacterial patterns correlate with various health outcomes. Most commercial tests use 16S rRNA gene sequencing to identify bacterial species and provide reports on diversity metrics, beneficial bacteria ratios, and comparisons to reference populations.

Studies suggest that while microbiome testing can provide insights into gut health status, the clinical utility remains limited due to high inter-individual variation and the dynamic nature of microbial communities. Research indicates that factors like diet, medications, stress, and lifestyle significantly influence microbiome composition, making single-timepoint testing potentially less informative than longitudinal monitoring. Some studies have found correlations between certain bacterial patterns and conditions like inflammatory bowel disease, obesity, and metabolic dysfunction, though causation remains unclear.

Current limitations include lack of standardization across testing platforms, variable analytical methods, and limited reference databases for diverse populations. Research suggests that while microbiome testing may be useful for tracking changes over time or identifying potential dysbiosis, the predictive value for specific health outcomes remains modest. Most medical professionals recommend using microbiome testing as supplementary information rather than a primary diagnostic tool, particularly given the rapidly evolving understanding of microbiome-health relationships.

Known Interactions

  • Antibiotic use within 3 months can significantly alter results
  • Probiotic supplements may temporarily modify bacterial ratios
  • Recent dietary changes can affect microbial composition for several weeks
  • Sample collection timing and storage conditions impact result accuracy

Legal Status by Country

📍

Your country (United States)

OTC
✈️

Available without prescription in:

Australia, Brazil, Canada, China, Colombia, Germany, India, Israel, Japan, Mexico, Netherlands, Panama, Russia, South Korea, Switzerland, Thailand, Turkey, UAE, United Kingdom, United States

Australia
OTC
✈️Brazil
OTC
Canada
OTC
China
OTC
✈️Colombia
OTC
Germany
OTC
✈️India
OTC
✈️Israel
OTC
Japan
OTC
✈️Mexico
OTC
Netherlands
OTC
✈️Panama
OTC
Russia
OTC
✈️South Korea
OTC
Switzerland
OTC
✈️Thailand
OTC
✈️Turkey
OTC
✈️UAE
OTC
United Kingdom
OTC
📍United States
OTC

📍 = your selected country · ✈️ = medical tourism destination · Always verify current local regulations before travel.

Key Research

Last verified: 2026-03-19